Megan E. McLaughlin
Papers
1
Total Citations
33
H-Index
1
About
Megan E. McLaughlin is a leading figure in the development of high-throughput antibody discovery platforms, with a primary focus on phage-displayed synthetic antibody libraries. Her most-cited work, "Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries" (2015, 33 citations), addresses a critical bottleneck in biomedical research: the growing demand for high-quality antibodies that traditional monoclonal technologies cannot meet. McLaughlin’s major contribution lies in engineering scalable selection processes that dramatically increase the efficiency and throughput of antibody identification, enabling the rapid generation of binders for diverse targets. This work has significant implications for both basic research and clinical applications, where robust, renewable antibody reagents are essential. By advancing synthetic library design and automation-compatible workflows, she has helped democratize access to sophisticated antibody tools. Her achievements underscore a commitment to solving practical challenges in protein engineering, making her a key contributor to the next generation of immunoreagent development.
Research Focus
Key Achievements
Top Papers
- 1